|
|
40
|
|
|
66721
|
|
|
CATAFLAM 1.8MG/ML SUSP (NVS/COL) DICLOFENAC P
|
|
|
DICLOFENAC POTASSIUM
|
|
|
CATAFLAM
|
|
|
120ML
|
|
|
C
|
|
|
8.75
|
|
|
0.07
|
|
|
1.8MG/ML
|
|
|
SUSPENSION
|
|
|
0
|
|
|
ML
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
1 TD
|
|
|
3
|
|
|
No
|
|
|
28080492
|
|
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|